Mon. 1 Apr 2024, 8:02am ET
Benzinga
Earnings, Earnings Beats, Earnings Misses, News
TriSalus Life Sciences (NASDAQ:TLSI) reported quarterly losses of $(1.56) per share which missed the analyst consensus estimate of $(0.69) by 126.09 percent. The company reported quarterly sales of $5.721 million which beat the analyst consensus estimate of $5.453 million by 4.91 percent. This is a 77.34 percent increase over sales of $3.226 million the same period last year.